Dr. Long is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2100 Erwin Rd
Durham, NC 27705Phone+1 919-620-4467
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1987 - 1990
Vanderbilt University Medical CenterResidency, Internal Medicine, 1983 - 1986
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1983
Certifications & Licensure
CA State Medical License 1987 - Present
NC State Medical License 1996 - 2025
VA State Medical License 2003 - 2006
TN State Medical License 1984 - 1987- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402) Start of enrollment: 2006 Nov 01
- Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403) Start of enrollment: 2007 Aug 01
- Trial of CMV Specific DLIs From 3-6/6 HLA Matched Family Member Following Nonmyeloablative Allo SCT Start of enrollment: 2011 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Exploring facilitators and barriers to daily chlorhexidine gluconate bathing in adult patients undergoing hematopoietic stem cell transplantation.Ashley L Artese, Michele Sainvil, Laura J Fish, Lauren Hill, Tamara Somers
Supportive Care in Cancer. 2024-11-28 - 2 citationsFinancial Toxicity and Quality of Life in Patients Undergoing Stem-Cell Transplant Evaluation: A Single-Center Analysis.S M Qasim Hussaini, Yi Ren, Alessandro Racioppi, Meagan V Lew, Lauren Bohannon
JCO Oncology Practice. 2024-03-01 - 10 citationsA Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease.Chenyu Lin, Rachel A DiCioccio, Tarek Haykal, William C McManigle, Zhiguo Li
Transplantation and Cellular Therapy. 2023-03-01
Abstracts/Posters
- Decreased Mortality after the First Year of Allogeneic Hematopoietic Stem Cell Transplant in Recipients of Umbilical Cord Blood Vs. Matched Related or Matched Unrelate...Gwynn D. Long, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Evaluation of the Oral SYK Inhibitor Fostamatinib in Patients after Allogeneic Transplantation for Chronic Graft-Versus-Host DiseaseGwynn D. Long, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Geriatric Assessment Identifies Impairments in Younger Candidates for Allogeneic Hematopoietic Stem Cell TransplantationGwynn D. Long, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
